The impact of transfusion burden and comorbidities on the prognosis of patients with myelodysplastic syndromes

SARICI A., AR M. C., Yokus O., ONGOREN S., Ayer M., Altindal S., ...Daha Fazla

TRANSFUSION AND APHERESIS SCIENCE, cilt.59, sa.5, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 59 Sayı: 5
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1016/j.transci.2020.102845
  • Dergi Adı: TRANSFUSION AND APHERESIS SCIENCE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, Biotechnology Research Abstracts, EMBASE, MEDLINE
  • İnönü Üniversitesi Adresli: Evet

Özet

Purpose: Early comorbidity detection has been reported to be associated with treatment-related outcomes in several diseases. Two main goals of the present study were to investigate both the impact of comorbidities and transfusion frequencies on the survival and quality of life of patients with myelodysplastic syndromes (MDS).